Lv5
1404 积分 2023-08-29 加入
Dual-payload ADCs move into first oncology clinical trials
3天前
已完结
Intratumoral T cell activation kills tumors regardless of T cell specificity
2个月前
已完结
Cathepsin Family Proteases in Prodrug Design: Recent Advances
2个月前
已完结
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker
2个月前
已完结
A Self-Delivering Oxygen Modulator for Breast Cancer Immunotherapy via Pyroptosis Induction and PD-L1 Degradation
2个月前
已完结
A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy
2个月前
已完结
Core-Shell Distinct Nanodrug Showing On-Demand Sequential Drug Release To Act on Multiple Cell Types for Synergistic Anticancer Therapy
2个月前
已完结
Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy
2个月前
已完结
Leveraging endogenous MMPs for drug delivery in the cancer environment
2个月前
已完结
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody
3个月前
已完结